VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 366 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $268,000 | -19.5% | 1,500 | 0.0% | 0.04% | -24.1% |
| Q2 2015 | $333,000 | +11.7% | 1,500 | 0.0% | 0.06% | +7.4% |
| Q1 2015 | $298,000 | -9.4% | 1,500 | -34.8% | 0.05% | -21.7% |
| Q4 2014 | $329,000 | +8.9% | 2,300 | 0.0% | 0.07% | +19.0% |
| Q3 2014 | $302,000 | +4.1% | 2,300 | 0.0% | 0.06% | +7.4% |
| Q2 2014 | $290,000 | -4.3% | 2,300 | 0.0% | 0.05% | -6.9% |
| Q1 2014 | $303,000 | +12.2% | 2,300 | 0.0% | 0.06% | +7.4% |
| Q4 2013 | $270,000 | -28.2% | 2,300 | -36.1% | 0.05% | -32.5% |
| Q3 2013 | $376,000 | +21.3% | 3,600 | 0.0% | 0.08% | +23.1% |
| Q2 2013 | $310,000 | – | 3,600 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |